Hyperlipidaemia and cardiovascular disease.
作者信息
Wray R
出版信息
Curr Opin Lipidol. 1995 Dec;6(6):U160-4. doi: 10.1097/00041433-199512000-00015.
Abstract
摘要
相似文献
1
Hyperlipidaemia and cardiovascular disease.
Curr Opin Lipidol. 1995 Dec;6(6):U160-4. doi: 10.1097/00041433-199512000-00015.
2
Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S).斯堪的纳维亚辛伐他汀生存研究（4S）中的基线血清胆固醇水平及治疗效果
Lancet. 1995 May 20;345(8960):1274-5.
3
The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.斯堪的纳维亚辛伐他汀生存研究（4S）糖尿病受试者亚组分析：对冠心病预防的启示
Diabetes Care. 1997 Apr;20(4):469-71. doi: 10.2337/diacare.20.4.469.
4
Cholesterol synthesis inhibitors in hyperlipidaemia.
Lancet. 1988 Mar 12;1(8585):597. doi: 10.1016/s0140-6736(88)91401-8.
5
Effects of simvastatin on serum lipids and atherosclerosis in WHHL rabbits.辛伐他汀对WHHL兔血脂及动脉粥样硬化的影响。
Clin Ther. 1991 May-Jun;13(3):417-24.
6
Cholesterol-lowering, simvastatin, and coronary heart disease.降低胆固醇、辛伐他汀与冠心病
Lancet. 1995 Mar 4;345(8949):592. doi: 10.1016/s0140-6736(95)90505-7.
7
Hyperlipidaemia and cardiovascular disease.
Curr Opin Lipidol. 1997 Jun;8(3):U40-1. doi: 10.1097/00041433-199706000-00016.
8
Therapy and clinical trials.治疗与临床试验。
Curr Opin Lipidol. 1997 Jun;8(3):U44-6. doi: 10.1097/00041433-199706000-00018.
9
Simvastatin decreases mortality.辛伐他汀可降低死亡率。
J Fam Pract. 1995 May;40(5):498-9.
10
Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).降低冠状动脉事件风险：来自斯堪的纳维亚辛伐他汀生存研究（4S）的证据。
Am J Cardiol. 1995 Sep 28;76(9):64C-68C. doi: 10.1016/s0002-9149(99)80473-1.
Zotero 插件